|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-8-16
|
|
pubmed:abstractText |
Combination antihypertensive therapy with an inhibitor of the renin-angiotensin system (RAS) and a calcium channel blocker (CCB) is a rational approach to achieve blood pressure (BP) goals in patients with hypertension, and may provide additional cardiovascular protection compared to other strategies in special populations. This article reviews the rationale for, and evidence supporting, the use of newer fixed-dose combinations of RAS inhibitors and CCBs, with particular emphasis on perindopril/amlodipine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2263-76
|
|
pubmed:meshHeading |
pubmed-meshheading:20690889-Amlodipine,
pubmed-meshheading:20690889-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:20690889-Antihypertensive Agents,
pubmed-meshheading:20690889-Calcium Channel Blockers,
pubmed-meshheading:20690889-Drug Therapy, Combination,
pubmed-meshheading:20690889-Humans,
pubmed-meshheading:20690889-Hypertension,
pubmed-meshheading:20690889-Perindopril,
pubmed-meshheading:20690889-Renin-Angiotensin System,
pubmed-meshheading:20690889-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
|
|
pubmed:affiliation |
Dept of Internal Medicine & Arterial Hypertension, Avicenne Hospital, Bobigny Cedex, France. jean-jacques.mourad@avc.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|
